urotoday.com
Dec 17, 2024, 23:36
Durvalumab and chemotherapy improves survival in MIBC – Uro Today
UroToday.com shared a post on X:
“NIAGARA trial shows durvalumab + chemotherapy improves survival in MIBC.
Tom Powles, Barts Cancer Institute (Queen Mary) and Zach Klaassen discuss the NIAGARA trial results which examined the addition of durvalumab to cisplatin-based chemotherapy in the perioperative setting for muscle-invasive bladder cancer, representing the largest trial in this space with 1,000 patients.
Full Video on UroToday.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36
Dec 17, 2024, 23:36
Dec 17, 2024, 23:14
Dec 17, 2024, 23:14
Dec 17, 2024, 23:14